Anne M. Spanjaart

649 total citations
14 papers, 304 citations indexed

About

Anne M. Spanjaart is a scholar working on Oncology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Anne M. Spanjaart has authored 14 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Anne M. Spanjaart's work include CAR-T cell therapy research (8 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Ion channel regulation and function (3 papers). Anne M. Spanjaart is often cited by papers focused on CAR-T cell therapy research (8 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Ion channel regulation and function (3 papers). Anne M. Spanjaart collaborates with scholars based in Netherlands, United States and France. Anne M. Spanjaart's co-authors include Hanno L. Tan, Abdennasser Bardai, Marieke T. Blom, Marie José Kersten, Roland D. Thijs, Henk J. Brouwer, Robert J. Lamberts, Jocelyn Berdowski, Josemir W. Sander and Rudolph W. Koster and has published in prestigious journals such as PLoS ONE, European Heart Journal and Quality of Life Research.

In The Last Decade

Anne M. Spanjaart

12 papers receiving 304 citations

Peers

Countries citing papers authored by Anne M. Spanjaart

Since Specialization

Citations

This map shows the geographic impact of Anne M. Spanjaart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne M. Spanjaart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne M. Spanjaart more than expected).

Fields of papers citing papers by Anne M. Spanjaart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne M. Spanjaart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne M. Spanjaart. The network helps show where Anne M. Spanjaart may publish in the future.

Co-authorship network of co-authors of Anne M. Spanjaart

This figure shows the co-authorship network connecting the top 25 collaborators of Anne M. Spanjaart. A scholar is included among the top collaborators of Anne M. Spanjaart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne M. Spanjaart. Anne M. Spanjaart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Patient-Reported Outcomes of CAR T-Cell Therapy in Non-Hodgkin Lymphoma Patients and Their Impact on Survival 2025 ·Transplantation and Cellular Therapy ·Anne M. Spanjaart, (unknown), Catherine Rioufol, Delphine Maucort‐Boulch, Sylvain Roche, Vanessa Beijamini, (unknown), Hervé Ghesquières, Marie José Kersten, María Gomes da Silva	0
2	Health-related quality of life dynamics: modeling insights from immunotherapy 2024 ·Quality of Life Research ·(unknown), Anne M. Spanjaart, (unknown), (unknown), Marie José Kersten, Mohammad S. Jalali	2
3	Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma 2023 ·Leukemia & lymphoma ·Maria T. Kuipers, Anne M. Spanjaart, Francesca Bonifazi, (unknown), Pier Luigi Zinzani, Catherine Thiéblemont, Mathilde Baudet, Bart J. Biemond, Wouter E.M. Kok, Marie José Kersten	0
4	Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities 2023 ·Cancers ·(unknown), (unknown), (unknown), Jaap A. van Doesum, Anne M. Spanjaart, Margot Jak, Pim Mutsaers, Suzanne van Dorp, Joost S.P. Vermaat, Marjolein van der Poel, Lisanne V. van Dijk, Marie José Kersten, (unknown), Tom van Meerten	9
5	Cellular therapy in lymphoma 2023 ·Hematological Oncology ·Anna Sureda, Pieternella J. Lugtenburg, Marie José Kersten, Marion Subklewe, Anne M. Spanjaart, Nirali N. Shah, Lucila Nassif Kerbauy, (unknown), (unknown), (unknown), Michelle Poon, (unknown), Manali Kamdar, Caron A. Jacobson	3
6	Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapy 2023 ·Blood Advances ·(unknown), (unknown), Ankie Kleinjan, Jaap A. van Doesum, Anne M. Spanjaart, Pim Mutsaers, Margot Jak, Marjolein van der Poel, Maria T. Kuipers, Judit A. Adam, Arjan Diepstra, Lianne Koens, Suzanne van Dorp, Joost S.P. Vermaat, (unknown), Marie José Kersten, Tom van Meerten	6
7	Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities 2022 ·JCO Oncology Practice ·Anne M. Spanjaart, (unknown), Milan Kos, Pim Mutsaers, Pieternella J. Lugtenburg, Tom van Meerten, Jaap A. van Doesum, Monique C. Minnema, Margot Jak, Suzanne van Dorp, Joost S.P. Vermaat, Marjolein van der Poel, Martijn G.H. van Oijen, Maria T. Kuipers, Inger S. Nijhof, Marie José Kersten	7
8	Health-related quality of life in cancer immunotherapy: a systematic perspective, using causal loop diagrams 2022 ·Quality of Life Research ·(unknown), Anne M. Spanjaart, (unknown), Bernard Rachet, Stéphane Dalle, Marie José Kersten, Delphine Maucort‐Boulch, Mohammad S. Jalali	13
9	CD19-directed CAR T-cell therapy in B-cell NHL 2020 ·Current Opinion in Oncology ·Marie José Kersten, Anne M. Spanjaart, Catherine Thiéblemont	23
10	SCN5A mutation type and topology are associated with the risk of ventricular arrhythmia by sodium channel blockers 2018 ·International Journal of Cardiology ·Ahmad S. Amin, Yolan J. Reckman, Elena Arbelo, Anne M. Spanjaart, Pieter G. Postema, Rafik Tadros, Michael W.T. Tanck, Maarten P. van den Berg, Arthur A.M. Wilde, Hanno L. Tan	18
11	Correction: Epilepsy Is a Risk Factor for Sudden Cardiac Arrest in the General Population 2012 ·PLoS ONE ·Abdennasser Bardai, Robert J. Lamberts, Marieke T. Blom, Anne M. Spanjaart, Jocelyn Berdowski, (unknown), Henk J. Brouwer, Rudolph W. Koster, Josemir W. Sander, Roland D. Thijs, Hanno L. Tan	18
12	Epilepsy Is a Risk Factor for Sudden Cardiac Arrest in the General Population 2012 ·PLoS ONE ·Abdennasser Bardai, Robert J. Lamberts, Marieke T. Blom, Anne M. Spanjaart, Jocelyn Berdowski, (unknown), Henk J. Brouwer, Rudolph W. Koster, Josemir W. Sander, Roland D. Thijs, Hanno L. Tan	87
13	Variants in the 3′ untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner 2011 ·European Heart Journal ·Ahmad S. Amin, John R. Giudicessi, Anke J. Tijsen, Anne M. Spanjaart, Yolan J. Reckman, Christine A. Klemens, Michael W.T. Tanck, Jamie D. Kapplinger, Nynke Hofman, Moritz F. Sinner, Martina Müller‐Nurasyid, Wino J. Wijnen, Hanno L. Tan, Connie R. Bezzina, Esther E. Creemers, Arthur A.M. Wilde, Michael J. Ackerman, Yigal M. Pinto	94
14	Differential Changes in QTc Duration during In-Hospital Haloperidol Use 2011 ·PLoS ONE ·Marieke T. Blom, Abdennasser Bardai, Barbara C. Van Munster, (unknown), Hendrik de Jong, Daniel A. van Hoeijen, Anne M. Spanjaart, Anthonius de Boer, Sophia E. de Rooij, Hanno L. Tan	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact